Targeting tumor-specific glycosylation patterns to enable advanced therapies
We are dedicated to improving the lives of cancer patients by enabling treatment options that go beyond today’s standard of care.
With exceptional experience in glycobiology and therapeutic antibody development, our mission is to develop advanced biologics that facilitate novel approaches to cancer therapies.
Learn More about Glycotope and our Leadership Team
Our proprietary technology platform enables the development of antibodies with unrivaled tumor-specificity
Our pipeline of antibody therapeutics includes in-house and partnered pre-clinical programs
We aim to continuously expand our collaborations with industry partners and academic centers to further exploit the unique potential of our technology